From the Computational Genetics Laboratory at the University of Pennsylvania (www.epistasis.org)

Saturday, January 25, 2014

My take of the FDA's decision to regulate 23andMe

In 2013 the FDA ordered 23andMe to stop selling it's genetic testing services for health-related purposes. This was a very controversial ruling that generated lots of discussion in the media. A collection of links to media coverage and opinions put together by writer David Dobbs can be found here. My take on the issue can be found in this Dartmouth Medicine Magazine piece.

0 Comments:

About Me

Edward Rose Professor of Informatics,
Director of the Institute for Biomedical Informatics, Director of the Division of Informatics in the Department of Biostatistics and Epidemiology,
Senior Associate Dean for Informatics,
The Perelman School of Medicine,
University of Pennsylvania